Given Imaging Ltd. Report issue

For profit Phase 2 Phase 4
Founded: Duluth GA United States (1998)
Status: Acquired by Covidien (2013) → now Medtronic (2014)

Organization Overview

First Clinical Trial
2008
NCT00731172
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (1)

adalimumab (humira) (1 trial)

Drugs in Phase 2 Trials (1)

glatiramer acetate (copaxone) (1 trial)

Drugs in Other Trials (2)

Key: Given Imaging Ltd. (0) Acquired (2)

lactulose (cephulac) (1 trial)

rifaximin (xifaxan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Crohn Disease (Phase 2)

Enterocolitis (Phase 4)

Inflammation (Phase 4)

Spondylarthritis (Phase 4)

Spondylitis (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4